Articul8 launches Bivia to bring domain-specific decision intelligence to enterprise AI agents
Crosslist, a Leading Cross Listing Software, Outlines a Practical Framework for Building an Ecommerce Strategy
Proofpoint Introduces Flex to Help Customers Invest with Confidence as Security Needs Evolve
ESET introduces ESET NeoCortex: Cybersecurity AI model with 200 times lower training costs and a never-go-rogue design
Kobalt Labs Named to the 2026 CB Insights’ 100 Most Promising Fintech Startups
MINNEAPOLIS, Nov. 28, 2022 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc . (Nasdaq: PBLA), a clinical stage…
TN-401 is being developed for the treatment of genetic arrhythmogenic right ventricular cardiomyopathy (ARVC) caused…
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation…
MIAMI, Nov. 28, 2022 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused…
YONKERS, N.Y., Nov. 28, 2022 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology…
Presentation highlights data from PRO-CL-002 Phase 2 study of Providence’s mRNA COVID-19 vaccine candidate, PTX-COVID19-B…
Newly published phase 2b trial data show those treated with roflumilast cream had significantly greater…
Publication details the efficacy and safety of rezafungin dosed once-weekly versus the current of care…
BOSTON, Nov. 28, 2022 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage…
WATERTOWN, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) — Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology…
IND filing followed encouraging preclinical studies conducted in collaboration with Yale Cancer Center that showed…
Novel best-in-class MEK-RAF complex inhibitor IK-595 targets RAS pathway; IND in 2023 Novel paralog-selective TEAD…
SAN DIEGO, Nov. 28, 2022 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today provided…
CNM-Au8 demonstrated low contrast vision improvement and global neurological improvement (low contrast vision, cognition, upper…
Innovative trial addresses second most common dementia after Alzheimer’s disease, now enrolling patients at up…
ROCHESTER, N.Y., Nov. 28, 2022 (GLOBE NEWSWIRE) — Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology…
THE WOODLANDS, Texas, Nov. 28, 2022 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today…
MALVERN, Pa., Nov. 28, 2022 (GLOBE NEWSWIRE) — Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ:…
Study finds patients with Fragile X who have a highly methylated FMR1 gene that were…
Primary endpoint in Intention to Treat (ITT) was not met despite large absolute reductions in…